A case study describing a Phase I dose escalation and cohort expansion study of an immune checkpoint inhibitor in patients with advanced solid tumors.
Explore related content and topics

A Blueprint to Success: Onboarding a Medical Writer
Onboarding is the process of welcoming new employees into an organization and providing them with the tools, resources, and knowledge to become…

Select Characteristics of Recreational Opioid Users Undergoing a Human Abuse Potential Study
Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to…

Healthcare Intelligence: Q&A with Ewoud-Jan van Hoogdalem
How can we keep healthcare affordable and accessible to all? How can we use science to benefit humans? Asking Ewoud-Jan van Hoogdalem a question…